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(IATS), which has 17 serotypes based on Habs serotypes 1–12 plus 
5 more serotypes from other serotyping systems (Stanislavsky and 
Lam, 1997). A subsequent study added 3 more serotypes to bring the 
total to 20 (Liu and Wang, 1990). Note that from this point onward in 
this review, the serotypes of P. aeruginosa strains mentioned are based 
on the IATS classification. Although it has been known that varia-
tions in the cell-surface lipopolysaccharide (LPS) of P. aeruginosa 
are responsible for serotyping, knowledge of the chemical structures 
of LPS and the underlying genetics of the biosynthetic process was 
lacking and prompted new research interests in this area.
The IATS serotyping scheme has been generally effective for classify-
ing P. aeruginosa strains that are wildtype organisms producing smooth 
LPS possessing three distinct domains, namely, lipid A, core oligosac-
charide (OS), and O polysaccharides or O antigens (O-Ag). This is not 
often the case in clinical settings as many of these isolates are found to 
be either partially lacking or completely devoid of O-Ag. Serotyping 
of chronic bacterial isolates from cystic fibrosis (CF) patients for epi-
demiological studies was particularly problematic because a very high 
proportion of these bacteria were found to be either polytypeable by 
more than one serotyping antisera or non-typable (NT). This has 
prompted the generation of new typing reagents based on monoclo-
nal antibodies (mAbs) specific against each of the original 17 IATS 
serotypes (Lam et al., 1987a,b). In ensuing studies, comparison of the 
P. aeruginosa typing efficiencies with the complete set of anti-O1 to 
anti-O17 mAbs versus other methods, such as phage-susceptibility 
typing, pyocin typing, and restriction fragment length polymorphism 
(RFLP) DNA fingerprinting was performed (Ojeniyi et al., 1989, 1990; 
Speert et al., 1994); these methods differed substantially in their capac-
ity to indentify unique typing patterns. Although RFLP was deemed to 
have the greatest discrimination power, LPS-based serotyping appears 
IntroductIon and hIstorIcal perspectIves
To classify the differences among Pseudomonas aeruginosa strains 
isolated from environmental or clinical settings, serological methods 
have been employed whereby polyclonal antisera were raised against 
representative strains, then cross-adsorbed with other P. aeruginosa 
strains in order to yield a collection of strain-specific antisera. In 
order to exploit the specificity of the antibodies within these antisera, 
a number of immunochemical techniques were employed including 
slide agglutination tests and gel-diffusion precipitation reactions. The 
former constitutes a rather simple method of visualizing clumping of 
bacteria on a microscope slide by a small aliquot of specific antiserum 
in a matter of seconds, while the latter allows the diffusion of antibod-
ies and antigen, usually bacterial cell lysates, from adjacent sample 
wells in agarose gels until equivalent amounts of these reagents meet 
to form visible precipitins (Mutharia and Lam, 2007). Interestingly, 
the precipitin reactions also provide the resolution to distinguish 
between cross-reacting groups, thereby giving rise to subgrouping 
among a specific serotype, for instance, serogroups 2a2b, 2a2c, etc. 
(Stanislavsky and Lam, 1997). Though tedious, these serotyping 
methods were the gold standards approximately 30 years ago, and 
are still being used by certain public health laboratories due to the 
low cost and rapidity in obtaining results. Since various laboratories 
from different parts of the world prepare their own antisera, many 
P. aeruginosa serotyping schemes have been established, such as the 
Homma, Habs, Lanyi and Bergan, and Fisher Immunotyping systems 
(reviewed in Stanislavsky and Lam, 1997). In order to standardize 
results stemming from the different serotyping systems, Liu et al. 
(1983) coordinated a special meeting between the P. aeruginosa sero-
typing experts, with the initiative giving rise to a standardized sero-
type classification termed the International Antigenic Typing Scheme 
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Table 1 | O-Antigen repeating units which compose the 20 IATS reference strains.
IATS serotype O-specific antigen repeat*
O1 →4)-d-GalNAc-(1 → 4)-d-GlcNAc3NAcA-d-(β1→3)-d-FucNAc-(1→3)-d-QuiNAc-(1→
O2 →4)-d-ManNAc3NAmA-(β1→4)-l-GulNAc3NAcA-(1→3)-d-FucNAc-(β1→
O5 →4)-d-ManNAc3NAmA-(β1→4)-d-ManNAc3NAcA-(β1→3)-d-FucNAc-(1→
O16 →4)-d-ManNAc3NAmA-(β1→4)-d-ManNAc3NAcA-(β1→3)-d-FucNAc-(β1→
O18 →4)-l-GulNAc3NAmA-(1→4)-d-ManNAc3NAcA-(β1→3)-d-FucNAc-(1→
O20 →4)-l-GulNAc3NAmA-(1→4)-d-ManNAc3NAcA-(β1→3)-d-FucNAc4OAc-(1→
O3 →2)-l-Rha3OAc-(1→6)-d-GlcNAc-(1→4)-l-GalNAc4OAcA-(13)-d-QuiNAc4NSHb (β1→
O4 →2)-l-Rha-(1→3)-l-FucNAc-(1→3)-l-FucNAc-(1→3)-d-QuiNAc-(1→
O6 →3)-l-Rha-(1→4)-d-GalNAc3OAcAN-(1→4)-d-GalNFoA-(1→3)-d-QuiNAc-(1→
O7 →4)-Pse4OAc5NRHb7NFo-(2→4)-d-Xyl-(β1→3)-d-FucNAc-(1→
O8 →4)-Pse4OAc5NAc7NFo-(2→4)-d-Xyl-(β1→3)-d-FucNAc-(1→
O9** →3′)-Pse4OAc5NAc7NRHb-(β2→4)-d-FucNAc-(1→3)-d-QuiNAc-(β1→
O10 →3)-l-Rha2OAc-(1→4)-l-GalNAcA-(1→3)-d-QuiNAc-(1→
O19 →3)-l-Rha-(1→4)-l-GalNAcA-(1→3)-d-QuiNAc-(1→
O11 →2)-d-Glc-(β1→3)-l-FucNAc-(1→3)-d-FucNAc-(β1→
O12 →8)-8eLeg5NAc7NAc-(2→3)-l-FucNAm-(1→3)-d-QuiNAc-(1→
O13 →)-l-Rha-(1→3)-l-Rha-(1→4)-d-GalNAc3OAcA-(1→3)-d-QuiNAc-(β1→
O14 →)[d-Glc-1→3)]-l-Rha-(1→3)-l-Rha-(1→4)-d-GalNAc3OAcA-(1→3)-d-QuiNAc-(β1→
O15 →2)-d-Ribf-(β1→4)-d-GalNAc-(1→
O17 →4)-l-Rha-(1→3)-d-ManNAc-(β1→
*Adapted from Knirel et al. (2006), O-Ag repeats are clustered according to structural similarity. Conserved sugars, colored by backbone structure, are adorned 
with various side groups depicting the diverse phenotypes generated by the OSA gene cluster throughout all 20 serotypes. Anomeric conformations are α unless 
marked β. Sugars have the pyranose form except ribose in O15. Ac, acetyl; 8eLeg, 5,7-diamino-3,5,7,9-tetradeoxy-l-glycero-d-galacto-non-2-ulosonic (8-epilegio-
naminic) acid; Fo, formyl; FucN, 2-amino-2,6-dideoxy-galactose; GalN, 2-amino-2-deoxy-galactose; GlcNA, 2-amino-2-deoxy-glucuronic acid; GulNA, 2-amino-
2-deoxy-guluronic acid; ManN 2-amino-2-deoxy-mannose; ManNA, 2-amino-2-deoxy-mannuronic acid; N, amino; NAc, acetamido; NAµ, acetamidino; OAc, O-acetyl; 
Pse, 5,7-diamino-3,5,7,9-tetradeoxy-l-glycero-l-manno-non-2-ulosonic (pseudaminic) acid; QuiN, 2-amino-2,6-dideoxyglucose; Rha, rhamnose; RHb (R)-3-hydroxybu-
tanoyl; Rib, ribose; SHb, (S)-3-hydroxybutanoyl.
In the polymer, QuiNAc is linked to the pseudaminic acid via the 3-hydroxybutanoyl group.
**QuiNAc is linked to the pseudaminic acid via the 3-hydroxybutanoyl group.
preferable for other indications because it is the simplest to perform. 
The use of mAb typing reagents was found to be more specific and 
accurate than the use of polyclonal antibody typing kits in assigning a 
specific serotype designation to many of the polytypeable P. aeruginosa 
isolates (Dasgupta et al., 1994). However, to classify strains that have 
been determined as NT by serotyping, other methods are required, 
for instance, the use of molecular techniques (discussed below as a 
consequence of sequencing results of all 20 IATS O-Ag biosynthesis 
gene clusters). This provided the rationale for investigating LPS bio-
synthesis and its assembly using genetic and biochemical approaches.
GenetIcs of o-specIfIc antIGen bIosynthesIs
Most P. aeruginosa strains produce two different forms of O-Ag, one of 
which contains a homopolymer of d-rhamnose, arranged in α1 → 3, 
α1 → 2, α1 → 3 trisaccharide repeats. This homopolymeric d-rham-
nan is the common polysaccharide antigen (CPA; formerly termed 
A band) among P. aeruginosa strains. More details of the properties 
of CPA will be discussed in later sections. The other form of O-Ag 
produced by P. aeruginosa is a heteropolymer with three to five dis-
tinct sugars in its repeat units, and is named O-specific antigen (OSA; 
formerly termed B band). The differences of the composition of the O 
units form the basis of the IATS serotyping scheme. Knirel et al. (2006) 
have made a significant contribution to our understanding of all the 
serotypes by  systematically  elucidating the chemical structures of the 
OSA of all 20 IATS serotypes (Table 1). To appreciate the complex-
ity and diversity of LPS produced by P. aeruginosa, it is noteworthy 
that heterogeneity exists in the chain length of either form of O-Ag 
present on the cell surface used to “cap” the core OS of P. aeruginosa 
(Figure 1). This accounts for the “ladder-banding” pattern when LPS 
from P. aeruginosa is analyzed by silver-stained SDS-PAGE gels and 
Western immunoblotting (Rocchetta et al., 1998a).
The importance of the OSA toward virulence and its use in serotyp-
ing has made it an attractive target for genetic studies to help under-
stand both the plasticity of this region of the LPS and the complex steps 
of OSA biosynthesis. OSA biosynthesis follows the Wzy-dependent 
pathway model, originally proposed by Whitfield (1995); it involves 
the sequential activities of a series of integral inner membrane (IM) 
proteins, for which we have recently obtained comprehensive topo-
logical data helping to explain their respective functions (Islam et al., 
2010). In this model, OSA sugar repeats are sequentially built on the 
lipid carrier undecaprenyl pyrophosphate (UndPP) on the cytoplas-
mic face of the IM. The UndPP-linked OSA repeats are then translo-
cated to the periplasmic face of the IM by the flippase Wzx (Burrows 
and Lam, 1999), where they are polymerized by Wzy (De Kievit et al., 
1995) through a putative catch-and-release mechanism (Islam et al., 
2011), to modal lengths regulated by Wzz
1
 (Burrows et al., 1997) and 
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FIgure 1 | representations of the heterogeneity/diversity of the LPS 
glycoforms present on the surface of a single P. aeruginosa cell. Genetic 
defects in members of various assembly pathway genes and their resultant 
changes to the variety of LPS glycoforms present have been indicated, with “” 
or “” representing their presence or absence, respectively. Substitutions of 
various lipid A and core OS sugars with phosphate groups and l-Ala have been 
indicated with yellow circles and red diamonds, respectively. The OSA polymer 
from serotype O5 has been displayed as a representative polymer.
Wzz
2
 (Daniels et al., 2002). The modal length of OSA imparted by 
Wzz
2
 (40–50 repeat length) is longer than that imparted by Wzz
1
 
(12–16 repeats and 22–30 repeats; Daniels et al., 2002). However, 
Wzz
1
 is apparently more important for virulence than Wzz
2
 (Kintz 
et al., 2008). Finally, the complete OSA chain is ligated to lipid A-core 
by the O-Ag ligase WaaL (Abeyrathne et al., 2005; Abeyrathne and 
Lam, 2007). Preliminary investigations mapped the OSA cluster to 
37 min of the P. aeruginosa PAO1 (serotype O5) genome (Lightfoot 
Lam et al. Pseudomonas aeruginosa LPS
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presented the sequences of a set of primers for PCR amplification of 
each of the IATS serotypes, meaning that a PCR-based approach can 
be used to correctly type clinical isolates that have previously been 
evaluated as NT by any typing antisera. However, thus far, there has 
been no systematic study conducted by any group to test the capabil-
ity of using these primers for consistently typing clinical strains of 
P. aeruginosa even though the potential to do so exists. These initial 
genetic investigations helped to reveal differences among the OSA 
clusters; worth noting is the anomaly discovered regarding the entire 
loss of the OSA cluster in the O15 serotype. Strains that belong to this 
serotype were previously identified using both polyclonal antibody 
typing kits and mAb-based serotyping (Lam et al., 1987b). It was 
proposed by Raymond et al. (2002) that in serotype O15, the genes 
involved in its OSA biosynthesis may not necessarily be residing in 
the usual OSA locus as in other serotypes. Additionally, in serotype 
O6, the wzy gene does not reside in the OSA cluster (Belanger et al., 
1999). Further, in serotype O5, the transcriptional start site for wzx 
exists within the wzy gene, and there is a large IS at the 3′ end of the 
O5 cluster upstream of wbpM (Burrows et al., 1996). This variation 
helps to explain the diversity of the LPS in P. aeruginosa as a property 
of the genetic differences among the IATS serotypes. Other factors 
that influence the OSA diversity are outlined in the following sections.
evIdence of horIzontal Gene transfer reveals the presence of 
conserved and duplIcated clusters In certaIn serotypes
The high conservation of the wbpM gene and its localization at the 3′ 
end of the OSA loci among all 20 serotypes is not the only commonal-
ity among all of the OSA loci. A major factor in genetic reassortment 
and Lam, 1993), corresponding to pa3141 to pa3160 in the anno-
tated genome of strain PAO1 (Stover et al., 2000). This first reported 
LPS OSA cluster was isolated from a cosmid-based genomic library. 
Clone pFV100 from the library was able to complement mutant ge6, 
a Tn5–751 insertional mutant of PAO1, defective in B band (OSA) 
biosynthesis (Lightfoot and Lam, 1993). Subsequently, Burrows et al. 
(1996) obtained the sequence of the entire OSA cluster. To characterize 
the function of the genes encoded in this cluster, knockout mutant 
constructs were generated for each of the genes and the mutants 
were examined for their effect on LPS production in P. aeruginosa. 
The list of OSA biosynthesis genes in this serotype O5 cluster and 
their functions were determined based on genetic studies as well as 
biochemical and chemical evidence (Figure 2A; Table 2, Burrows et 
al., 1996). Following the success in characterizing the O5 OSA bio-
synthesis locus, the sequences of the O6 (Belanger et al., 1999) and 
O11 (Dean et al., 1999) OSA loci were also determined. Comparisons 
among the newly sequenced loci revealed that all three OSA loci were 
flanked by himD/ihfB (pa3161) on the 5′ end and terminated with 
wbpM (pa3141) on the 3′ end. These observations are essential for 
establishing the conserved chromosomal locus for the OSA cluster, 
though the genes within the locus are the most varied in the P. aer-
uginosa genomes regardless of serotype. This information eventually 
allowed Raymond et al. (2002) to clone and sequence the OSA loci 
from all 20 IATS serotypes. Based on their sequencing data, the general 
genetic structures of the OSA loci of all the serotypes could be divided 
into 11 distinct groups based on the protein families that the genes in 
these loci encode, as well as the presence of insertion sequences (IS) 
and deletions (Figure 2B; Raymond et al., 2002). This group has also 
Table 2 | P. aeruginosa PAO1 serotype O5 OSA biosynthesis cluster*.
gene Proposed/demonstrated function Mol% g + C references
wzz /pa3160 OSA chain length regulator 49.5 Burrows et al. (1997), Daniels et al. (2002)
wbpA/pa3159 UDP-N-acetyl-d-glucosamine 6-dehydrogenase 54.5 Miller et al. (2004)
wbpB/pa3158 UDP-2-acetamido-2-deoxy-d-glucuronic 52.8 Westman et al. (2009) 
 acid 3-dehydrogenase
wbpC/pa3157 Possible O-acetyltransferase 53.1 
wbpD/pa3156 UDP-2-acetamido-3-amino-2,3-dideoxy-d-glucuronic 53.9 Wenzel et al. (2005), Westman et al. (2009) 
 acid N-acetyltransferase
wbpE/pa3155 UDP-2-acetamido-2-dideoxy-d-ribo-hex-3-uluronic 52.8 Westman et al. (2009) 
 acid transaminase
wzy/pa3154 OSA α-polymerase 44.6 De Kievit et al. (1995), Islam et al. (2010), 
   Islam et al. (2011)
wzx/pa3153 OSA unit flippase 49.3 Burrows and Lam (1999), Islam et al. (2010)
hisH2/pa3152 Imidazole glycerol phosphate synthase subunit 49.3 King et al. (2009)
hisF2/pa3151 Imidazole glycerol phosphate synthase subunit 50.0 King et al. (2009)
wbpG/pa3150 Amidotransferase 44.5 
wbpH/pa3149 Glycosyltransferase 45.6 
wbpI/pa3148 UDP-N-acetylglucosamine 2-epimerase 50.2 Westman et al. (2009)
wbpJ/pa3147 Glycosyltransferase (GT-4) 54.5 
wbpK/pa3146 NAD-dependent epimerase/dehydratase 56.8 
wbpL/pa3145 Glycosyltransferase 55.5 Rocchetta et al. (1998a)
wbpM/pa3141 Nucleotide sugar epimerase/dehydratase 61.9 Creuzenet and Lam (2001)
*Modified from Burrows et al. (1996), the information in this table has been updated with references which indicate that either genetic or biochemical evidence have 
been collected to demonstrate the function of each of these genes within the OSA biosynthesis cluster of PAO1 serotype O5. Note that in contrast to the genome 
of P. aeruginosa, which has a relatively high mol% G + C content (67%), the genes within this cluster showed significantly lower mol% G + C, ranging from 45.2 to 
61.9%, evidence of horizontal gene transfer.
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FIgure 2 | Organization of the genes within OSA biosynthesis clusters. 
(A) OSA biosynthesis cluster of serotype O5 adapted from Burrows et al. 
(1996). The gene cluster is located on the complementary strand; genes 
which match the PFAM designation are colored accordingly. Genes not 
involved in OSA biosynthesis are depicted in gray including a large insertion 
sequence (IS). (B) Adapted from Raymond et al. (2002), the OSA biosynthesis 
gene clusters were organized into 11 groups based on sequence 
conservation. Genes were designated using the PFAM database; specific 
protein families which occur a minimum of three times throughout all 20 OSA 
biosynthesis clusters are represented by a specific color. A red outline depicts 
an ORF with potential transmembrane-spanning domains. Previously 
identified genes are labeled above the respected cluster if present within the 
serotype. Insertion sequences (IS) present within genes are depicted by a 
secondary gray box.
Lam et al. Pseudomonas aeruginosa LPS
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wbpP, and wbpS encode the enzymes for the three metabolic steps 
that convert UDP-GlcNAc by oxidation (WbpO), epimerization 
(WbpP), and amidotransfer (WbpS) to form the uronamide sugar 
precursor UDP-GalNAcAN for O6 OSA. Interestingly, functional 
homologs of these three genes were found in Escherichia coli O121. 
As well, homologs of these three genes were also found in Francisella 
tularensis (King et al., 2010); however, they have not been tested to 
determine whether they could complement knockout mutants of the 
P. aeruginosa genes to restore production of O6 LPS that contains 
GalNAcAN in its O-Ag unit. Therefore, P. aeruginosa and other 
bacterial pathogens likely acquired genes for the biosynthesis of the 
abovementioned UDP-sugars from common ancestors. However, 
investigation of the evolutionary derivations and lineages of these 
pathways is beyond the scope of this review.
evIdence of dIversIty In lps expressIon In P. aeruginosa due to 
chromosomal InsertIons
Large chromosomal inversions (LCIs), which can be induced by 
ISs, persist throughout Gram-negative bacteria and have altered the 
balance between chromosomal stability and variability. Clonal iso-
lates taken from CF patients were found to contain additional, non-
conserved LCIs (Schmidt et al., 1996). P. aeruginosa “clone C,” found 
in various geographic locations and in non-CF patients (Kidd et al., 
2011), possesses a particular additional sequence, IS6100, which 
was first discovered in Mycobacterium tuberculosis and known to 
cause genetic rearrangements in heterologous hosts. The LCIs of the 
“clone C” strains have been associated with wbpM (pa3141) disrup-
tion causing loss of the OSA (Kresse et al., 2003). The genomes of 
two CF isolates were compared to that of the wildtype PAO1, with 
regions of high variability localized to the OSA biosynthesis locus. 
Targeted sequencing of the OSA cluster provided a high-resolution 
view of the genetic changes that arise during clonal infection of CF 
patients. Genomes of all late-stage clinical isolates contained ISs, as 
judged by gel electrophoresis (Spencer et al., 2003). The OSA region 
of a clonal isolate (strain 1–60) was nearly identical to serotype O1 
except for the presence of a large 1.5-kb IS, which disrupted a reading 
frame responsible for the biosynthesis of an unspecified nucleotide 
sugar. Additionally, a second strain (2–164) was found to contain a 
2-bp deletion in wbpQ, which has not yet been characterized. Both 
of these observed mutations caused defects in LPS production and 
conferred a NT phenotype. Interestingly, some of the earlier NT 
strains did not contain the IS elements (Spencer et al., 2003). Strain-
specific islands were discovered with high similarity to previously 
identified sequences (e.g., PAGI-1 in O-Ag biosynthesis) as well as 
some phage-related sequences; however, these contained a low mol% 
G + C content possibly indicating acquisition from other bacterial 
species (Spencer et al., 2003), since the P. aeruginosa genome has a 
high mol% G + C content. Whole-genome sequencing has begun 
to provide snapshots of these genetic changes, which occur during 
clonal infection; future work using this approach may provide a 
roadmap for navigating the infection stages of P. aeruginosa.
lysoGenIc conversIon by bacterIophaGe alters the osa 
serotype to promote resIstance
A natural part of bacteriophage biology is engagement of a lyso-
genic cycle wherein a temperate phage invades a bacterial cell and 
incorporates its genetic material into the host genome, leading to the 
is horizontal gene transfer (HGT), i.e., the direct transmission of 
genetic information across the species barrier, which often results 
in similar/identical gene products. Interestingly, Dean and Goldberg 
(2000) probed all 20 serotypes for the presence of genes that are 
conserved in the O11 OSA biosynthesis cluster, and discovered that 
the IATS O17 strain possesses a cryptic copy of the O11 locus within 
its genome. The O11 cluster was apparently rendered non-functional 
due to the presence of IS:SPA11B disrupting the 5′ end of the wzy 
gene. However, when a complete O11 OSA cluster was supplied in 
trans, LPS produced by the complemented strain reacted with anti-
O11 antiserum in Western immunoblotting. This suggested that the 
cryptic O11 serotype genes found within the O17 strain were at 
one time functional. The presence of a secondary locus within one 
genome lends support to HGT. Apparently, the OSA LPS genes for the 
O17 serotype that were acquired or have evolved may have caused a 
gradual loss of function or suppression to the O11 OSA biosynthesis 
gene cluster through the incorporation of an IS element. Interestingly, 
the O17 OSA serotype is very similar to the Burkholderia cepacia 
serogroup O5 antigen, confirming that this may be an ancestral locus 
which was acquired by HGT (Dean and Goldberg, 2000). Similarly, 
Raymond et al. (2002) discovered the presence of an additional 
cryptic locus corresponding to the O3 cluster within the genome of 
serotype O15, with further investigation revealing that the O3 cluster 
in the O15 strain was rendered non-functional due to IS elements at 
two different sites within the cluster.
Evidence that HGT contributes to the diversity of P. aeruginosa 
LPS is not limited to transfer of the entire OSA biosynthesis locus. 
Varying degrees of genetic information exchange between bacte-
ria are apparent since bacterial pathogens of different genera share 
conserved metabolic pathways for the biosynthesis of nucleotide 
sugars. A number of rare sugars are found in the OSA of P. aer-
uginosa LPS, e.g., l-FucNAc (a constituent of the O11 OSA), di-
N-acetylated mannuronic acid (d-ManNAc3NAcA, a constituent 
of the O5 OSA), and a uronamide sugar GalNAcAN (a constituent 
of O6 OSA). The metabolic pathways for the biosynthesis of the 
nucleotide-activated precursors for these rare sugars are only found 
in a few bacterial pathogens but not in humans (Kneidinger et al., 
2003; Westman et al., 2008, 2009; King et al., 2010). The biosynthe-
sis of UDP-l-FucNAc from the substrate UDP-d-GlcNAc, requires 
the products of three genes from the serotype O11 OSA cluster, 
namely, wbjB, wbjC, and wbjD. Two sets of functional homologs 
of these three genes are found in Staphylococcus aureus, namely 
cap5E-cap5F-cap5G and cap8E-cap8F-cap8G for the biosynthesis 
of serogroup-5 and serogroup-8 capsular polysaccharides, respec-
tively (Kneidinger et al., 2003). The complexity of the biosynthesis 
of the UDP-activated precursor of d-ManNAc3NAcA requires five 
steps. Indeed, the activity of the encoded products of wbpA, wbpB, 
wbpE, wbpD, and wbpI, acting in this particular order, and also 
starting with UDP-GlcNAc as the starting substrate, have been fully 
characterized (Westman et al., 2008, 2009). The same pathway is 
shared by Bordetella pertussis as it also possesses d-ManNAc3NAcA 
as a sugar in its LPS. However, only four of the five genes, wlbA, 
wlbB, wlbC, wlbD, which are functional homologs of wbpB, wbpE, 
wbpD, and wbpI, respectively, are localized within the O-Ag bio-
synthesis gene clusters. Two copies of the homolog of wbpA were 
found elsewhere in the B. pertussis genome (Westman et al., 2008). 
In a separate investigation, our group has determined that wbpO, 
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(Kunkel and Erie, 2005). Mutations in this region are known to 
cause loss of DNA proof reading thereby increasing the likelihood of 
mutant phenotypes which may convey survival advantages (Leclerc 
et al., 1996). This “hypermutable” phenotype was observed in 20% 
of P. aeruginosa isolates collected from CF airways and absent in 
isolates collected from blood and from the airway of non-CF patients 
(Oliver et al., 2000). One of the major genes responsible for the MMR 
mechanism is mutS; inactivation of this gene effectively shuts off the 
MMR cascade. Genetic analysis of the mutS gene from the previously 
characterized hypermutable P. aeruginosa strain JMSMA7 revealed a 
3.3-kb IS and an 8-nucleotide repeat which flanked a 54-nucleotide 
deletion (Oliver et al., 2000). Interestingly, contained within the 3.3-
kb IS lies another 1.2-kb IS element that is 90% homologous to IS222 
from the P. aeruginosa D3 phage (Kropinski et al., 1994; Oliver et al., 
2000). This region was interpreted as a veritable “hot-spot” of recom-
bination within the mutS gene promoting its loss of function and 
increasing the number of mutations (Oliver et al., 2002). An in-depth 
longitudinal study was undertaken by Smith et al. (2006) to examine 
the presence of the mutator phenotype in CF patients. The infor-
mation gained from this study was used to further characterize the 
hypermutable isolates and determine the locations of these genetic 
errors. Sequencing of genes in two CF isolates taken at 6 months 
and a comparable isolate taken at 96 months during time course 
experiments revealed the accumulation of 68 mutations, wherein 13 
were associated with virulence factors including genes associated with 
O-Ag biosynthesis (Smith et al., 2006). A continuing in-depth study 
using the genomes of these two isolates revealed an apparent increase 
in mutations within genes responsible for antibiotic resistance, as well 
as in lasR, a gene responsible for the regulation of quorum sensing 
in P. aeruginosa (Mena et al., 2008). The inactivation of lasR and 
subsequently rhlI in the hypermutable phenotype may result in a 
decrease of migA expression as indicated earlier by Yang et al. (2000). 
MigA is a glycosyltransferase responsible for the uncapped core OS 
phenotype, under the control of the RhlI–RhlR system (described 
below); when inactivated, the levels of MigA decrease causing an 
accumulation of “core-plus-one,” a LPS glycoform with a single OSA 
repeat (Yang et al., 2000; Figure 1), a less virulent form of LPS. This 
degree of genotype plasticity is proposed to aid in the survival of 
bacteria within stressful environments during the transition to a 
chronic infection (Smith et al., 2006).
Quorum-sensInG alters core os structure that affects o-aG 
lIGatIon
Cell density-dependent gene regulation plays an integral role in cell-
surface virulence factor expression, altering gene expression based 
on population size (Whiteley et al., 1999). As previously mentioned, 
most P. aeruginosa CF isolates from chronically infected patients 
are devoid of OSA and begin to favor the typical “rough” pheno-
type, i.e., producing LPS that lacks the full-length O antigen side 
chain, being non-motile and non-piliated (Hancock et al., 1983). 
Although previous studies have shown the genetic relationship of 
the alginate-based mucoid phenotype (Ma et al., 1998), the regula-
tion of changes governing the transition from smooth to rough LPS 
is not well defined. The “mucus inducible gene” migA (described 
above) is a putative glycosyltransferase and was discovered when 
P. aeruginosa was grown in the presence of CF mucus (Wang et 
al., 1996). Expression of the migA gene was found to be a result of 
 propagation of phage DNA during host cell replication. This part of 
the phage life cycle could also lead to the incorporation of exogenous 
bacterial genes into the host genome (Miller et al., 1974). The D3 
phage is a temperate phage that readily infects P. aeruginosa (Cavenagh 
and Miller, 1986). LPS-specific phage-dependent conversion of the 
OSA occurs throughout Gram-negative bacteria (Robbins et al., 1965; 
Bagdian et al., 1966). Holloway and Cooper (1962) observed that after 
strain PAO1 (serotype O5) was infected with D3 phage, at least 20% of 
the new colonies from subcultures tested could not be agglutinated by 
O5-specific typing antiserum. The mechanism of the changes occur-
ring at the bacterial cell surface was unknown at the time. In a later 
study, a similar observation was made by the Hancock group who 
showed that lysogenized PAO1 cells had an altered LPS phenotype 
(Hancock et al., 1983), and this change was later determined to be 
due to the addition of an acetyl group at position 4 of the fucosamine 
residue and an alteration in the linkage of the trisaccharide repeat-
ing unit bond from α1 → 4 to β1 → 4 (Kuzio and Kropinski, 1983). 
In a more recent study by our group, a region of the D3 genome 
was found to contain a gene that hybridized in Southern blots to an 
O-acetylation gene found in the PAO1 genome (Newton et al., 2001). 
This region spans 3.6 kb of the D3 genome, and contains three genes: 
(i) oac (encodes an O-acetylase), which adds an O-acetyl group to 
the OSA FucNAc residue, (ii) wzyβ (encodes a β-polymerase) which 
polymerizes the OSA repeats to form β1 → 4 linkages, and (iii) iap 
(encodes an α-polymerase inhibitor, a small 31 amino acid peptide 
with a single transmembrane domain). Iap possesses the activity to 
render Wzy
α 
non-functional thereby preventing the formation of the 
usual α1 → 4 linkage among O-Ag subunits of strain PAO1 (Newton 
et al., 2001). Expression of this operon in trans produced an LPS band-
ing pattern similar to that of LPS from O16, and these bands reacted 
strongly with the anti-O16 mAb MF47-4 in Western immunoblotting 
but not with the anti-O5 mAb MF15-4 (Newton et al., 2001). O-Ag 
subunits of serotypes O2 and O16 are linked by β1 → 4 bonds, and 
both serotype strains contain a functional wzy
α
 that is actively being 
repressed by a previously undetected iap. Interestingly, the wzyβ gene 
in O2 and O16 was not localized to the OSA biosynthesis cluster, 
further supporting the idea that this could be a D3 phage-associated 
gene. The authors initially suggested that wzyβ and iap identified in P. 
aerugionsa O2 and O16 strains are xenologs of the D3 phage. However 
the mol% G + C of wzyβ and iap respectively are inconsistent when 
compared to the mol% G + C values of both the PAO1 and the D3 
phage genomes; therefore, the authors attributed the origin of these 
genes to an exogenous source (Kaluzny et al., 2007).
chromosomal InstabIlIty promotes mutatIons that decrease 
vIrulence and Increase survIval
It has become dogma that once P. aeruginosa has colonized the lungs 
of CF patients, it adapts to a biofilm lifestyle to protect the bacterial 
community from hostile host defense and promote survival. The 
emergence of mucoid colony morphology is a hallmark of such 
adaptation and provides selective pressures that favor the occur-
rence of mutator phenotypes. These mutators in the bacterial com-
munity accumulate genetic changes resulting in altered phenotypes 
and gene expression profiles. The cause of the mutator phenotype 
is the inactivation/suppression of the methyl-directed mismatch 
repair (MMR) mechanism used to repair DNA  replication errors 
and decrease the likelihood of homologous recombination events 
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the aGe of technoloGy broadens Gene expressIon 
InvestIGatIons
In silico-based algorithms and bioinformatic methods have moved 
to the forefront of genomic research, performing a variety of predic-
tions to provide a global view of genome expression profiles. When 
combined with microarray data, in silico modeling can be applied 
to examine an entire genome, particularly for investigating up and 
down regulations of genes throughout a longitudinal experiment. 
Using this approach, Oberhardt et al. (2010) examined the gene 
expression in a number of CF isolates throughout a progressive CF 
infection by a clonal strain of P. aeruginosa. They observed that the 
genes relating to LPS and capsule biosynthesis were downregulated 
during chronic CF infection. The development of new computer-
based programs and ever-improving novel DNA sequencing tech-
niques will help to broaden our understanding of the polymorphic 
nature of OSA of P. aeruginosa during CF infection.
structure, GenetIcs, and functIon of cpa (a band)
dIscovery of cpa
In the 1980s, CPA was detected to be a P. aeruginosa antigen that 
reacted with a human monoclonal antibody produced by Sawada’s 
group (Sawada et al., 1985). Further analysis found the antigen to be 
a neutral polysaccharide composed of d-rhamnose (d-Rha) that is 
separable as well as structurally and immunologically distinct from 
the predominant OSA (Yokota et al., 1987; Kocharova et al., 1988; 
Rivera et al., 1988). In a study by McGroarty’s group, the authors 
used gel filtration chromatography and a buffer containing deoxy-
cholate, which helped to disperse LPS from micelles and aggregates, 
to obtain two separate fractions of surface polysaccharide from P. 
aeruginosa (Rivera et al., 1988). The fast-migrating fraction con-
tained OSA (named B band) that was reactive to serotype-specific 
antibodies, while the slower-migrating fraction (CPA, i.e., A band) 
did not react with any of the mAbs that the Lam laboratory had 
raised against the IATS serotypes. Upon receiving the CPA from 
McGroarty, our group raised a number of hybridoma cell lines 
(e.g., N1C9, N1F10) that secreted mAbs that are specific against 
quorum sensing (Whiteley et al., 1999), dependent on the release of 
autoinducer molecules by P. aeruginosa into the local environment. 
When the bacterial density increases to an appropriate level, the local 
concentration of autoinducer molecules reaches a critical threshold 
past which they can consistently bind to transcription regulators 
across the entire cell population, resulting in alternative gene expres-
sion across the entire community (Fuqua et al., 1994). The migA 
gene was found to be under the control of RhlI–RhlR regulatory 
system, one of the two principal quorum-sensing systems, due to 
its severe decrease in expression in a rhlI–rhlR double knockout as 
compared to wildtype. Furthermore, it possesses an upstream las-
box-like sequence (CT-N
11
)-AG), known to be a quorum-sensing 
recognition site for quorum-sensing regulators (Yang et al., 2000). 
Interestingly, overexpression of migA resulted in a loss of “core-plus-
one” but not the higher molecular weight LPS, leading the authors to 
speculate the existence of a secondary glycosyltransferase (Yang et al., 
2000). Recently that second glycosyltransferase was identified by our 
group as wapR, located 158-bp downstream of the core biosynthesis 
locus (Poon et al., 2008). Genetic and biophysical analysis of these 
two genes and their products revealed that both are responsible for 
core modifications in LPS biosynthesis (Figure 3). The expression of 
these genes results in an altered core structure: migA is responsible 
for the addition of the l-rhamnoseA (l-RhaA) in the α1 → 6 link-
age, preventing the addition of O-Ag to lipid A-core by the O-Ag 
ligase WaaL (Yang et al., 2000; Poon et al., 2008). The wapR gene is 
responsible for the addition of the core sugar l-RhaB, creating the 
favored linkage site for the addition of the O-Ag by WaaL (Poon 
et al., 2008). A genomic knockout of wapR resulted in the loss of 
higher molecular weight LPS bands, corresponding with the addi-
tion of O-Ag to lipid A-core. Work is currently underway in our 
laboratory to establish the relationship between migA and wapR gene 
expression. The cell density-dependent effects on gene regulation are 
of particular importance as CF isolates are often found in mature 
biofilms, a direct byproduct of quorum sensing.
FIgure 3 | Proposed CPA gene clusters of (A) P. aeruginosa PAO1, (B) PA14, (C) LeSB58, (e) PA7, and (D) P. fluorescens pfO-1. The organism-specific identifier 
for numbered genes of unknown function is indicated in brackets beside each organism.
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cosmid pFV3 was also found to be able to restore CPA biosynthesis 
in five (O7, O13, O14, O15, and O16) out of the six IATS sero-
types that lacked CPA LPS (Lightfoot and Lam, 1991). Sequencing 
and genetic analysis of this clone revealed a cluster of eight genes 
(Figure 3, rmd-wbpZ) that are required for CPA biosynthesis. 
Our group went on to construct a non-polar knockout mutant 
of each of these genes (Rocchetta and Lam, 1997; Rocchetta et al., 
1998a,b). Three of the genes rmd, gmd, wbpW (pa5454, pa5453, 
pa5452) plus another gene located in the alginate biosynthesis 
cluster, algC (pa5322), encode enzymes responsible for the bio-
synthesis of GDP-d-Rha, the nucleotide sugar precursor for CPA. 
The glycosyltransferase gene wbpL located in the OSA gene cluster 
described earlier was found to be required for the initiation of both 
CPA and OSA assembly (Rocchetta et al., 1998a). Another three 
genes in the cluster, wbpX, wbpY, and wbpZ (pa5449, pa5448, and 
pa5447), encode putative rhamnosyltransferases responsible for the 
specific linkages of the α1 → 3, α1 → 3, α1 → 2 bonds that form 
the d-Rha trisaccharide repeating unit (Rocchetta et al., 1998a). The 
last two genes, wzm and wzt (pa5451 and pa5450), encode proteins 
for an ABC transport system that transfers the UndPP-linked CPA 
polymer precursor across the IM to the periplasmic surface where 
CPA is ligated to lipid A-core to complete its synthesis (Rocchetta 
and Lam, 1997). Southern-blotting analysis revealed that this clus-
ter of eight genes is present in all of the 20 IATS reference strains, 
although some strains that do not produce CPA (O12, O13, O15, 
and O16) showed variation in the blotting profiles suggesting DNA 
rearrangement within the cluster (Currie et al., 1995).
In recent years, the genomes of several P. aeruginosa strains have 
been sequenced including PAO1 (serotype O5) (Stover et al., 2000), 
PA14 (serotype O10) (Lee et al., 2006), PA7 (a multidrug resistance 
serotype O12 strain; Roy et al., 2010), and the NT Liverpool Epidemic 
strain LESB58 (Winstanley et al., 2009). LESB58 has a rough LPS 
phenotype devoid of OSA; however, its genome sequence consists 
of the OSA biosynthesis locus that shares a high degree of homol-
ogy and gene organization with the serotype O6 OSA LPS cluster 
sequenced by Raymond et al. (2002). Analysis of these genomes 
revealed that all four strains contain the rmd-wbpZ eight-gene clus-
ter in a conserved manner. However, the clinical isolate LESB58 
contains a non-functional gmd that can be deemed a pseudogene. In 
three of the sequenced genomes (PAO1, PA14, and LESB58), imme-
diately adjacent to the rmd-wbpZ eight-gene cluster and located in 
the opposite strand, a five-gene cluster (pa5455–pa5459 in PAO1, 
pa14_7201-pa14_7205 in PA14, and paleas_5850-paleas_5854 in 
LESB58) was also present in a conserved manner (Figures 3A–C). 
This cluster of genes encoding putative glycosyltransferases (the first 
two genes in the cluster, blue), methyltransferases (the third and the 
fifth genes in the cluster, red) and an acetyltransferase (the fourth 
gene in the cluster, orange), was also proposed to be involved in CPA 
biosynthesis and modification (King et al., 2009). Mutation and 
complementation analyses of these five genes clearly showed that all 
five are required for CPA biosynthesis (Hao and Lam, unpublished 
data). This five-gene cluster is also found in the genome of strain 
PA7 (serotype O12; Figure 3E, pspa7_6253-pspa7_6257). However, 
unlike in the aforementioned three strains, this five-gene cluster is 
located on the same strand and is separated from the rmd-wbpZ 
eight-gene cluster by a 10-kb DNA fragment in PA7 (Figure 3). 
This could have resulted from a chromosomal rearrangement event 
CPA. Using mAb N1F10 in dot-blot and Western-immunoblotting 
analyses, the presence of CPA was detected in 14 of the 20 P. aer-
uginosa IATS serotypes. The strains that did not react to the mAb 
belong to serotypes O7, O12, O13, O14, O15, and O16 (Lam et al., 
1989; Currie et al., 1995). However, a majority of clinical P. aer-
uginosa isolates examined since then were found to be devoid of 
OSA but produce CPA as the predominant surface polysaccharide 
antigen (Lam et al., 1989; Weisner et al., 2007). In a separate study, 
CPA was found to be a receptor for bacteriophage A7, indicating 
its significance as a cell-surface polysaccharide component of P. 
aeruginosa and its role in the co-evolution with temperate bacte-
riophages (Rivera et al., 1992).
structural study of cpa
Structural elucidation of CPA from different P. aeruginosa strains 
has been reported. Yokota’s group was the first to discover that the 
predominant structure of the common polysaccharide from P. aer-
uginosa strain IID 1008 (ATCC 27584; Yokota et al., 1987) reactive 
to a human mAb is composed of a trisaccharide repeating unit: →3)
d-Rha(α1 → 3)d-Rha(α1 → 2)d-Rha(α1→. Our group prepared 
CPA from PAO1 (serotype O5; Arsenault et al., 1991) and by using 
high-field nuclear magnetic resonance (NMR) and mass spectrom-
etry (MS) methods, we collected data to show that this neutral 
polysaccharide contains a d-rhamnan with the same structural 
repeat as demonstrated by Yokota et al. (1987). Two other groups 
who examined CPA from a serotype O7 strain (Lanyi–Bergan clas-
sification; Kocharova et al., 1988) and strain PA103 (serotype O11; 
Choudhury et al., 2005) also observed the same trisaccharide repeat 
structure. However, aside from the predominant d-Rha trisaccha-
ride repeat units, small amounts of other components have also 
been reported with less consistency among the different studies. For 
example, the presence of 3-O-methylrhamnose, ribose, mannose, 
glucose, and a 3-O-methylhexose have been detected from CPA 
prepared from strain PAO1 (Arsenault et al., 1991); 3-O-methyl-
6-deoxyhexose, glucose, xylose, alanine, galactosamine, and phos-
phorus have all been reported as components of CPA fractions 
for strain IID 1008 (ATCC 27584; Yokota et al., 1987). Glucose, 
mannose, and phosphate have been found in the study of CPA 
from the O7 strain (Kocharova et al., 1988), while mannose and 
GlcNAc, as well as small amounts of O- and N-acetyl substitutions, 
were found in the CPA from strain PA103 (Choudhury et al., 2005). 
These differences reported in the minor components of CPA could 
be due to several factors including genuine strain differences, the 
details in the preparation of CPA, and the sensitivity and accuracy 
of the detection methods used. In conclusion, the precise structure 
of CPA has not been defined to date. Further study is currently 
underway in our lab to determine the identity of the initiating 
sugar, the terminal sugar, the position and amount of other sugar 
components, as well as the degree and position of the methylation 
and acetylation modifications of CPA from strain PAO1.
GenetIcs of cpa bIosynthesIs
A cosmid clone pFV3 that is able to restore CPA biosynthesis in a 
CPA-deficient mutant (strain AK1401) was first obtained from a 
cosmid library of P. aeruginosa prepared from strain PAO1. Mutant 
strain AK1401 was a phage-resistant mutant derived from the PAO1 
background (Lightfoot and Lam, 1991). When expressed in trans, 
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diversity of the complete and the truncated core OS (Kocíncová and 
Lam, 2011), hence more details on structural diversity of core OS 
can be found there. In general, core OS, which is the linker region 
between O-Ag and lipid A can be divided into two regions, namely, 
the inner and outer core.
structure of Inner core os
Composition of the sugar constituents in inner core OS is iden-
tical among P. aeruginosa strains and it consists of two residues 
of 3-deoxy-d-manno-octulosonic acid (KdoI and KdoII) and two 
residues of L-glycero-d-manno-heptose (HepI and HepII; Figure 4). 
The inner core is highly conserved when compared to other Gram-
negative bacteria. A distinguishing feature of the P. aeruginosa 
inner core is a high degree of phosphorylation that is essential for 
viability of P. aeruginosa, since mutation of either of the two genes 
(wapP and waaP) encoding kinases that are responsible for add-
ing phosphate groups to the inner core heptoses is lethal (Walsh 
et al., 2000). In most P. aeruginosa strains, three phosphorylation 
sites have been identified; positions 2 and 4 on HepI and position 
6 on HepII. In a CF isolate, HepII has been shown to possess an 
additional phosphorylation site on position 4 (Knirel et al., 2006). 
In theory, monophosphate, diphosphate, or triphosphate groups 
might occupy each of the phosphorylation sites (Kooistra et al., 
2003; Choudhury et al., 2005; Bystrova et al., 2006). Some of the 
analyzed P. aeruginosa strains have shown the non-stoichiomet-
ric substitution of a phosphate group on position 2 of HepI by 
 ethanolamine-phosphate or ethanolamine-diphosphate (Bystrova 
et al., 2006). However, Knirel et al. (2006) suggested that the actual 
content of phosphates and ethanolamine-phosphates in the inner 
core might be higher, since these phosphate groups can be released 
from the core during preparation of LPS prior to structural analy-
ses. In addition to phosphorylation, HepII is modified with another 
non-carbohydrate substituent, namely an O-carbamoyl group on 
position 7 (Beckmann et al., 1995).
structure of outer core os
The outer core of P. aeruginosa LPS is composed of one d-galactosa-
mine (GalN), one l-Rha, and three or four d-glucose (GlcI–GlcIV) 
residues. GalN is further substituted on position 2 with an alanyl 
(Ala) group or in some truncated core structures with an acetyl 
group (Sanchez Carballo et al., 1999; Choudhury et al., 2008). The 
outer core OS of P. aeruginosa has a unique feature; it exists in two 
structurally distinct glycoforms, called “uncapped” and “capped” 
(King et al., 2009). These two glycoforms basically differ in position 
and linkage of an l-Rha residue in each structure. The capped gly-
coform is covalently attached to O-Ag on l-RhaB that is 1,3-linked 
to GlcI, whereas the uncapped glycoform cannot be substituted 
with O-Ag and it contains an l-RhaA that is 1,6-linked to GlcII 
(Figure 4). The presence of this l-RhaA likely causes steric hin-
drance and prevents attachment of O-Ag to the uncapped core OS; 
it is also possible that this 1,6-linked l-Rha cannot be recognized 
by WaaL (O-Ag ligase) as part of the core OS receptor during the 
O-Ag ligation process.
Another variability in sugar composition of core OS is the presence 
or absence of a fourth Glc residue (GlcIV) in the uncapped core OS; 
among the core OSs of the 20 IATS serotypes, GlcIV is present in only 
nine (O2, O5, O7, O8, O10, O16, O18, O19, and O20; De Kievit and 
and might have disrupted the promoter region of this gene cluster, 
which would explain the lack of CPA expression in this strain. We 
also found that this genomic region from strain PA7 showed a much 
lower sequence identity to that of the other three strains. The strains 
PAO1, PA14, and LESB58 share more than 95% sequence identity 
in most of the proteins encoded by genes of the CPA biosynthe-
sis cluster, while PA7 showed less than 50% identity to these three 
strains. This may explain why the cosmid pFV3 did not complement 
CPA biosynthesis in this serotype while still being able to do so for 
the other five serotypes that lack CPA LPS. Interestingly, we found 
that homologous CPA biosynthesis genes are also present in the 
genome of P. fluorescens pfO-1 (Silby et al., 2009), in a conserved 
manner similar to P. aeruginosa PAO1 and PA14 (Figure 3D), show-
ing 54–75% amino acid sequence identity to these two strains. To 
date there is no report about the structure of LPS of P. fluorescens 
pfO-1. It would be interesting to study whether this strain produces 
the same CPA LPS, and whether it also produces two types of LPS 
as in P. aeruginosa.
The same structure of d-Rha repeating units [→3)
d-Rha(α1 → 3)d-Rha(α1 → 2)d-Rha(α1→)] has been reported for 
the LPS of several other bacterial species including the plant patho-
gen Xanthomonas campestris pv. phaseoli var. fuscans (Senchenkova 
et al., 2002), the opportunistic human pathogen Stenotrophomonas 
maltophilia serotype O7 (Winn and Wilkinson, 1998), P. syrin-
gae strains (Ovod et al., 1996), and a Burkholderia cepecia strain 
(Cerantola and Montrozier, 1997). However, to our knowledge, the 
OSA biosynthesis genes have not been identified and investigated 
in any of these bacterial strains.
functIonal study of cpa
Most P. aeruginosa strains simultaneously produce both OSA-
containing LPS and CPA-containing LPS, with the former being 
the more proportionally predominant LPS species. However, it was 
reported that due to long-term selective pressure against the OSA 
(which is the more immunogenic of the two O-Ag glycoforms), 
CPA is apparently selectively maintained as the preferred O-Ag on 
the cell surface of P. aeruginosa during chronic lung infection in CF 
patients, and becomes the major LPS antigen over time (Hancock 
et al., 1983; Lam et al., 1989).
Thus far, there is only limited information about the biological 
function of CPA besides being part of the P. aeruginosa cell wall. 
Our lab has demonstrated in a cell adhesion assay study that a 
rmd mutant of P. aeruginosa, defective in d-Rha biosynthesis and 
thereby CPA production, is significantly less efficient in adher-
ing to cultured human bronchial epithelial cells, suggesting that 
CPA may play an important role in adherence of P. aeruginosa to 
tissues (Matewish, 2004). More work is currently underway to 
investigate the significance of CPA for P. aeruginosa to attach to 
different surfaces using biophysical techniques based on atomic 
force microscopy (AFM).
contrIbutIon of varIatIons In core olIGosaccharIde 
to lps dIversIty
For the sake of full coverage of each region of the LPS molecule that 
contributes to diversity in the LPS produced by P. aeruginosa, in 
this section, we will briefly discuss the variability in core OS struc-
tures. Our group has recently published a review on the structural 
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for a number of bacteriophages and pyocins (Jarrell and Kropinski, 
1981a,b; Temple et al., 1986; Yokota et al., 1994; Michel-Briand and 
Baysse, 2002). For more details, see the section in this review on the 
role of LPS in host–pathogen interactions. In earlier studies of P. 
aeruginosa LPS biosynthesis, bacteriophages E79 and 2 Lindberg were 
used to select for spontaneous rough mutants that also had truncation 
within the core OS (Jarrell and Kropinski, 1981a,b; Dasgupta et al., 
1994). Two varieties of outer core truncations providing resistance 
to bacteriophages have been described, more specifically, the outer 
core of these structures in the mutant bacterial strains were composed 
of either (i) the first residue of outer core, GalN (representing the 
deepest truncation of core OS structure ever found in P. aeruginosa) 
or (ii) a disaccharide GalN–GlcII (Masoud et al., 1994; Sadovskaya 
et al., 1998; Sanchez Carballo et al., 1999). Similarly, pyocins (i.e., 
“defective phages”) produced by P. aeruginosa, that are able to kill 
susceptible cells of the same species but are unable to replicate within 
cells (Michel-Briand and Baysse, 2002), have been used to select for 
spontaneous rough mutants aiming to generate ones with truncations 
within the core region (Koval and Meadow, 1977). Another strategy 
to search for strains with core OS truncations has been to select for 
spontaneous mutants that would be resistant to a cationic antibiotic; 
our group used increasing concentrations of gentamicin to select for 
drug-resistant mutants (Dasgupta et al., 1994). However, the core OS 
structures from these gentamicin and pyocin-resistant strains have 
yet to be elucidated, and as such their chemical compositions remain 
unknown.
Lam, 1994; Bystrova et al., 2006). Additionally, a variable non-sugar 
substitution found in outer core OS is O-acetylation. P. aeruginosa 
strains display diversity in the degree of O-acetylation ranging from 
none to five acetyl groups (Bystrova et al., 2006). Since O-acetylation 
is non-stoichiometric, attempts to precisely identify and quantify all 
acetylated residues have been difficult. Thus far, only two specific 
residues have been found to be O-acetylated: RhaA, particularly when 
this residue is not further linked to GlcIV, and GlcII, as observed in a 
number of P. aeruginosa mutants with defects in core OS biosynthesis 
producing truncated core OS (Bystrova et al., 2006; Poon et al., 2008).
spontaneous core truncatIons
As mentioned above, phosphorylation of inner core heptoses is essen-
tial for P. aeruginosa cells. Each constituent of the entire inner core 
seems to be required for viability of P. aeruginosa; thus far all of the 
truncated OS structures that have been examined exhibited a com-
plete inner core, with defects only found in the outer core residues 
(Sadovskaya et al., 1998; Sanchez Carballo et al., 1999; Kooistra et al., 
2003; Choudhury et al., 2005). Preliminary observations also sug-
gested that GalN, the first residue of the outer core, might be essential 
for viability. This assumption was based on the inability to construct 
a mutant of wapG, which encodes a glycosyltransferase presumably 
responsible for transferring a GalN residue to the Hep residue in 
the core (Matewish, 2004). A spontaneous mutation causing trun-
cation of core OS under a selective pressure could be a significant 
source of core diversity. Core OS has been reported to be a receptor 
FIgure 4 | Structures of uncapped and capped glycoforms. The structures of the uncapped core oligosaccharide (A), and capped core oligosaccharide (B) are 
depicted. All the sugars shown have α configuration unless otherwise indicated. Asterisks depict variable substitutions, acetylation sites are shown since they have 
not been precisely identified. Ala, alanine; Cm, carbamoyl; Etn, ethanolamine; GalN, 2-amino-2-deoxy-galactose (galactosamine); Glc, glucose; Hep, l-glycero-d-manno-
heptose; Kdo, 3-deoxy-d-manno-oct-2-ulosonic acid; Rha, rhamnose. Adapted from King et al. (2009).
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cluster contains genes that are involved in the transportation of lipid 
A and ligation of O-Ag to the core (msbA and waaL, respectively). 
Two other genes, pa5002 and pa5003 have not been characterized; 
therefore, their functions are at present unknown.
Our group has reported the characterization of two transferase 
genes, migA (described above) and waaA, that are important for 
core OS biosynthesis, but are localized outside the usual core LPS 
gene locus. The waaA gene encodes a putative Kdo transferase (King 
et al., 2009). More recently, we have characterized a homolog of 
migA that is designated as wapR. The wapR gene turned out to be 
localized within the core OS gene cluster. Characterization of WapR 
showed that it is responsible for the transfer of l-RhaB, the other 
outer core rhamnose residue that is 1,6-linked to the GlcI of the 
capped core OS (Poon et al., 2008). We hypothesize that the ratio 
between expression levels of migA and wapR would influence the 
amount of capped and uncapped core OS being produced. Studies 
to understand the regulation of wapR are currently underway in 
our laboratory. Both putative rhamnosyltransferase enzymes, MigA 
and WapR, presumably utilize the same substrates, TDP-l-Rha as 
a sugar donor and core OS lacking l-Rha residues as an acceptor 
molecule. Therefore, they compete for the enzyme substrates and 
should impact on amounts of capped and uncapped glycoforms 
being produced. For instance, overproduction of MigA favors syn-
thesis of uncapped core, whereas an elevated level of WapR activity 
leads to higher amounts of capped core substituted with O-Ag. It is 
plausible that under certain conditions migA is upregulated while 
wapR is downregulated (or vice versa), which may consequently 
influence the amount of O-Ag on the cell surface of P. aeruginosa.
We recently discovered yet another transferase gene called 
wapB, which shares sequence homologies with both migA and 
wapR. The wapB gene encodes a putative 1,2-glucosyltransferase 
that is required for transfer of terminal GlcIV to uncapped core OS 
(Kocíncová et al., 2011). As not all of the P. aeruginosa strains pos-
sess GlcIV as a terminal sugar residue in their uncapped core OS, not 
all of the P. aeruginosa strains have the wapB gene. For instance, this 
gene is absent from the sequenced genome of P. aeruginosa PA7.
Other variability in the structure of the P. aeruginosa core OS 
arises from the different degrees of phosphorylation (including 
ethanolamine-phosphate) and acetylation patterns. However, the 
variability of these phosphatidyl or acetyl substitutions is non- 
stoichiometric and the genetic elements that account for these 
minor substitutions are unknown at present. Additionally, it has 
yet to be determined what role (if any) genetic events such as muta-
tions or mobile element insertions in core OS genes have played in 
the truncation of core OS, when rough LPS mutants were selected 
for resistance to bacteriophages/pyocins or antibiotics. Therefore, 
there are obvious areas concerning core biosynthesis and regulation 
that require further investigation.
structure and functIon dIversIty of lIpId a
structural dIversIty of P. aeruginosa lIpId a
The lipid A domain of LPS is a glucosamine-based lipid that anchors 
the LPS in the bacterial outer membrane (OM). The structure of P. 
aeruginosa lipid A has been studied in great detail using both MS 
and NMR techniques, and it has been reviewed by several groups 
(Knirel et al., 2006; King et al., 2009; Moskowitz and Ernst, 2010). 
Similar to lipid A of other Gram-negative bacteria, P. aeruginosa 
GenetIcs of core dIversIty due to Glycosyltransferases
Pseudomonas aeruginosa genomes possess a gene cluster (pa4996–
pa5012) encoding proteins that are known to be involved in core OS 
biosynthesis: HldE, MsbA, PA4998, WaaL, WapR, PA5001, PA5002, 
PA5003, WapH, WapO, PA5006, WapQ, WapP, WaaP, WapG, WaaC, 
and WaaF. The respective function of each of these proteins (either 
demonstrated or proposed based on homology comparisons) has 
been summarized (Table 3; for more detailed description, see a 
recent review by our group (King et al., 2009). Apart from the pres-
ence or absence of the GlcIV residue as a terminal sugar in uncapped 
core OS, the structures of core OS among P. aeruginosa strains are 
relatively conserved with no strain-to-strain variability in sugar 
composition. This observation is consistent with the discovery 
that the genes in the locus for core biosynthesis are well conserved 
among P. aeruginosa strains whose genomes have been sequenced. 
The amino acid identity of the gene products in this locus from 
one strain to the next is relatively high ranging from 77 to 100%. In 
addition to genes that encode kinases and heptosyltransferases, this 
Table 3 | genes involved or potentially involved in the core OS 
biosynthesis of P. aeruginosa. 
gene Proposed/demonstrated references 
 function
COre BIOSynTheSIS gene CLuSTer (PA4996-PA5012)
hldE/pa4996 Heptose biosynthesis King et al. (2009)
msbA#/pa4997 Transport lipid A-core Ghanei et al. (2007)
pa4998 Kinase King et al. (2009)
waaL#/pa4999 O antigen ligase Abeyrathne et al. 
  (2005), Abeyrathne 
  and Lam (2007)
wapR/pa5000 Glycosyltransferase (RhaB) Poon et al. (2008)
pa5001 Glycosyltransferase  King et al. (2009)
pa5002 Unknown 
pa5003 Unknown 
wapH/pa5004 Glycosyltransferase (GlcII) Matewish (2004)
wapO/pa5005 Carbamoyltransferase (King et al. (2009)
pa5006 Kinase King et al. (2009)
wapQ/pa5007 Heptose kinase Walsh et al. (2000)
wapP/Pa5008 Heptose kinase Walsh et al. (2000), 
  To (2006)
waaP/pa5009 Heptose kinase: position Walsh et al. (2000),  
 4 of HepI Zhao and Lam (2002), 
  Zhao et al. (2002)
wapG/pa5010 Glycosyltransferase (GalN) 
waaC/pa5011 Glycosyltransferase (HepI) De Kievit and Lam (1997)
waaF/pa5012 Glycosyltransferase (HepII) De Kievit and Lam (1997)
geneS LOCATeD OuTSIDe OF The COre BIOSynTheSIS CLuSTer
wapB/pa1014 glycosyltransferase (GlcIV) Kocíncová et al. (2011)
migA/pa0705 glycosyltransferase (RhaA) Poon et al. (2008)
waaA/pa4988 glycosyltransferase:  King et al. (2009) 
 (KdoI, KdoII)
# Indicates genes involved in cellular processes other than core biosynthesis.
Bold font indicates that biochemical or genetic evidence of involvement in P. 
aeruginosa core biosynthesis exists.
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 penta-acylated lipid A form, which is the predominant (∼75%) lipid 
A form of  laboratory P. aeruginosa strains, lacks the primary O-linked 
acyl substitution at position 3 of the GlcNI (Figure 5, lipid A form B; 
Kulshin et al., 1991).
As has been demonstrated in enteric bacteria such as S. enter-
ica (Guo et al., 1997, 1998), P. aeruginosa lipid A adopts different 
modifications in response to different environmental conditions 
encountered such as different growth medium and during human 
infection. For example, clinically isolated P. aeruginosa strains pro-
duce lipid A with modified structures. Lipid A from P. aeruginosa 
isolated from patients with acute clinical infections (such as blood, 
ear, eye, and urinary tract) or chronic non-CF infections such as 
bronchiectasis has a penta-acylated form that lacks the secondary 
acyl group at position 2 of the sugar GlcNI (Figure 5 lipid A form 
C; Ernst et al., 1999, 2003). Three different types of modifications 
have been observed for the lipid A structure of P. aeruginosa iso-
lates from CF patient airways. The first type of modification is 
observed in the majority of CF P. aeruginosa isolates: the addition 
of an O-linked secondary palmitate (16:0) to the 3-OH group of 
10:0(3-OH) at the 3′ position in sugar GlcNII (Figure 5 lipid A 
form D, blue; Guo et al., 1997, 1998). Less than half of CF isolates 
examined by the Miller group showed a second type of modifica-
tion to lipid A, the non-stoichiometric addition of aminoarabinose 
(4-amino-4-deoxy-l-arabinose, Ara4N) to either or both of the 
lipid A is composed of a diglucosamine biphosphate backbone 
[4-P-β-d-GlcNII-(1 → 6)-α-d-GlcNI-(1 → P], and O- and N- linked 
primary and secondary fatty acids. The major structural differences 
of lipid A are observed in the number, the position, the nature 
of the linked acyl groups, and the modification of the phosphate 
groups (Figure 5). For example, the chain lengths of the fatty acids 
attached to lipid A of P. aeruginosa (C
10
/C
12
) are shorter than those 
of E. coli and Salmonella enterica sv. Typhimurium (C
12
/C
14
; Trent, 
2004). Heterogeneity of lipid A structure has also been observed 
within different P. aeruginosa strains, which arises from different 
growth conditions and isolation sources.
The lipid A of laboratory-adapted P. aeruginosa strains (including 
PAO1, PAK, and PA14) grown in rich medium was found to exhibit 
a hexa-acylated form (∼25%; Figure 5 lipid A form A) or a penta-
acylated form (∼75%; Figure 5 lipid A form B; Bhat et al., 1990; 
Kulshin et al., 1991; Ernst et al., 1999; Moskowitz et al., 2004). The 
hexa-acylated form is a symmetrically acylated structure, with each 
sugar containing an N-linked 12:0(3-OH) [I-3-hydroxylauroyl] group 
at the 2 position, an O-linked 10:0(3-OH) [I-3-hydroxydecanoyl] 
group at the 3 position, and a secondary 12:0 (lauroyl) group linked 
to the 3-OH group of the primary N-linked 12:0(3-OH) at posi-
tion 2 (lipid A form A). Either or both of the secondary acyl groups 
could be non-stoichiometrically 2-hydroxylated (Figure 5 red 
labeled), converting 12:0 to 12:0(2-OH) (Kulshin et al., 1991). The 
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FIgure 5 | Different lipid A forms of P. aeruginosa and the proposed biosynthesis and modification pathway.
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et al., 2000, 2008). In P. aeruginosa, two putative LpxO homologs 
(LpxO1 and LpxO2, encoded by pa4512 and pa1936, respectively) 
were present; presumably each would hydroxylate one of the 
two secondary acyl chains (King et al., 2009). A newly identified 
deacylase enzyme PagL is believed to be involved in the removal 
of the primary 10:0(3-OH) group at the 3 position of GlcNI of 
the hexa-acylated lipid A (Figure 5, lipid A form A) to form the 
penta-acylated lipid (Figure 5, lipid A form B), and to convert the 
hepta-acylated lipid A (Figure 5, form E) to hexa-acylated lipid 
A (Figure 5, form D) in CF isolates (Ernst et al., 2006). As stated 
earlier, the lipid A from isolates of patients with acute infection 
or non-CF chronic infection lacks the secondary C
12
 acyl chain 
at GlcNI (Figure 5, lipid A form C; Ernst et al., 1999, 2003). This 
could be due to the lack of expression of one of the secondary 
acyltransferases lpxL, or the later removal of the secondary C
12
 
acyl group from lipid A (Figure 5, form A) by a novel deacylase 
enzyme. The OM palmitoyl transferase protein PagP was origi-
nally identified in Salmonella and is responsible for the addition 
of palmitate to lipid A (Guo et al., 1998). A PagP homolog in 
P. aeruginosa is proposed to catalyze the addition of palmitate 
to lipid A forms A and B to synthesize lipid A forms E and D 
that are found in CF patient airway isolates, respectively (Trent, 
2004). The hexa-acylated lipid A (form D) could also result from 
the removal of the primary 10:0(3-OH) group from the hepta-
acyl lipid A (form E) by the deacylase enzyme PagL. It is not 
known which of the two steps, i.e., the addition of palmitate or 
the removal of the primary 10:0(3-OH), occurs first. However, 
it has been confirmed that the occurrence of the hepta-acylated 
lipid A (form E) found only in isolates from CF patients with 
severe infection was due to the loss of PagL function (Ernst et 
al., 2006). Although an in vitro assay indicated that a PagP-like 
enzyme was present in the membranes (Trent, 2004) of P. aerugi-
nosa, to date, no pagP homolog has been identified in the genome 
(Stover et al., 2000). This could be due to low sequence similarity 
between these homologs. Similar to Salmonella, the addition of 
palmitate is regulated by the PhoP–PhoQ two-component regula-
tory system, as a phoP null mutant of P. aeruginosa is not able to 
synthesize palmitate-modified lipid A under inducing conditions 
for wildtype strains (such as limited Mg2+; Ernst et al., 1999). The 
biosynthesis pathway of aminoarabinose and its addition to lipid 
A has been well characterized in E. coli and S. enterica (reviewed 
by Trent, 2004 and Bishop, 2005). The gene ugd (also called pmrE) 
and the pmrHFIJKLM (also referred to as the arnBCADTEF) gene 
cluster have been identified and characterized to encode enzymes 
required for the biosynthesis of aminoarabinose as well as its 
transport across the IM and its ligation to lipid A (Trent, 2004; 
Bishop, 2005). These homologous genes were identified in a single 
cluster in the genome of P. aeruginosa PAO1 (pa3552–pa3559; 
Stover et al., 2000). As in E. coli and S. enterica, it was found 
that both PhoP–PhoQ and another two-component regulatory 
system PmrA–PmrB are involved in the regulation of the expres-
sion of these genes and the addition of aminoarabinose to lipid A 
(Moskowitz et al., 2004; Moskowitz and Ernst, 2010). Both systems 
can respond to Mg2+-limiting conditions (Mcphee et al., 2003, 
2006); moreover, the PmrA–PmrB system can also respond to the 
presence of CAMPs including polymyxin B causing activation of 
the transcription of the pmr gene cluster (Mcphee et al., 2003).
terminal phosphates (Figure 5 lipid A form D, green; Ernst et al., 
2007). A hepta-acylated lipid A (Figure 1 lipid A form E) found 
only in P. aeruginosa isolates from CF patients with very severe lung 
disease resulted from a third type of modification: the retention of 
the primary O-linked 10:0(3-OH) group at the 3 position of GlcNI 
(Ernst et al., 2003, 2007). Interestingly, the lipid A modifications 
observed in CF airway isolates (i.e., addition of palmitate and ami-
noarabinose) could be induced in laboratory strains, strains isolated 
from the environment, or non-CF clinical isolates under certain 
growth conditions including low Mg2+ concentration or the pres-
ence of cationic antimicrobial peptides (CAMPs) such as polymyxin 
B, indicating the enzymatic pathways for these modifications were 
intact and inducible in these strains (Bhat et al., 1990; Ernst et al., 
1999, 2003; Bedoux et al., 2004).
proposed bIosynthesIs and modIfIcatIon pathway of lIpId a
Over the past 20 years, the biosynthesis pathway of lipid A has 
first been experimentally determined in E. coli as well as other 
enteric bacteria and reviewed by Raetz and Whitfield (2002) and 
Trent (2004). Bioinformatics analysis indicates that the general 
scheme of lipid A biosynthesis pathways are highly conserved 
among Gram-negative bacteria, although various modifications 
are present in different bacteria (Trent, 2004). In P. aeruginosa, 
in contrast to the extensive and detailed structural elucidation of 
lipid A, most aspects of the biosynthesis pathway have not been 
investigated experimentally, perhaps due to the fact that the genet-
ics of lipid A biosynthesis were so thoroughly studied in enteric 
bacteria and that the pathway is relatively conserved. The current 
assumption about the biosynthesis pathways is mainly based on 
the identification of homologs to E. coli genes. Since all of the 
corresponding homologous genes encoding enzymes required for 
the biosynthesis of the important lipid A structure precursor lipid 
IV
A
 (Figure 5; including the primary acyltransferases LpxA and 
LpxD, the nucleotidase LpxH, the disaccharide synthase LpxB, and 
the kinase LpxK) were identified in the genome of P. aeruginosa, 
the biosynthesis of the lipid IV
A
 analog of P. aeruginosa is thought 
to be executed in a conserved manner as in E. coli and S. enterica. 
A detailed description of the proposed biosynthesis pathway of 
lipid IV
A
 was recently reviewed by our group (King et al., 2009). 
Not surprisingly, the lipid A primary acyl chain length of differ-
ent bacteria is determined by the chain length preference of the 
acyltransferase LpxA and LpxD (Dotson et al., 1998; Wyckoff 
et al., 1998).
Different forms of lipid A could then be synthesized and modi-
fied from lipid IV
A 
by different enzymes depending on the environ-
mental conditions (a proposed pathway is depicted in Figure 5). 
Two secondary acyltransferases (LpxL1 and LpxL2, encoded by 
pa3243 and pa0011, respectively) are proposed to transfer the 
secondary lauroyl groups to lipid IV
A
 to form the hexa-acyl lipid 
A (Figure 1. lipid A form A; Mohan et al., 1994; King et al., 2009). 
However, unlike in E. coli and S. enterica sv. Typhimurium, the 
addition of the first core sugar 3-deoxy-d-manno-oct-2-ulosonic 
acid (Kdo) to the lipid IV
A
 is not strictly necessary for the attach-
ment of the secondary acyl groups in P. aeruginosa (Goldman et 
al., 1988). The non-stoichiometric 2-hydroxylation of the sec-
ondary lauroyl group is proposed to be catalyzed by correspond-
ing homologs of S. enterica sv. Typhimurium LpxO (Gibbons 
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mutants disrupted in migA, wapR, and rmlC, respectively, and with 
defined core OS truncation characteristics were compared to their 
wildtype PAO1 parent strain in these studies. Significant changes 
were observed in cell mechanical properties among the mutant 
strains compared to the wildtype PAO1. The functions of migA 
and wapR have been described earlier; the rmlC gene is responsible 
for TDP-L-Rha biosynthesis and hence a rmlC mutant produces a 
defective core OS truncated at the RhaA and RhaB residues in the two 
glycoforms of the core OS (Figure 4). The data from these studies 
revealed that truncation of core OS enhanced both adhesive and 
cohesive forces by up to 10-fold, whereas changes in instantaneous 
elasticity were correlated with the presence of O-Ag. Using AFM 
to raster-scan bacterial cells in air in contact mode for each of the 
aforementioned four strains showed differences in the texture of the 
surface “smoothness.” Interestingly, LPS-“smooth” strain wildtype 
PAO1 with O-Ag exhibits rougher surface topography than rough 
strains, i.e., the mutant bacterial strains of migA, wapR, and rmlC 
(Figure 6). Using confocal laser scanning microscopy to quantify 
biofilm structural changes in these mutants, we observed that tex-
tural parameters varied with adhesion or the inverse of cohesion, 
while areal and volumetric parameters were linked to adhesion, 
cohesion, or the balance between them. Microcolonies formed by 
cells of the wildtype PAO1 had round perimeters, while the micro-
colonies formed by the mutant strains had more irregular edges 
(Figure 7; Lau et al., 2009b). These studies support the importance 
of O-Ag in the formation of cellular structures and the physiology 
of P. aerugionsa in a biofilm mode of growth. In a study by Ivanov 
et al. (2011), they showed that changes in the relative proportion 
of OSA modalities as well as the outright loss of OSA result in 
reduced virulence of P. aeruginosa consistent with diminished sur-
face adhesive forces, further supporting the role of LPS-mediated 
adhesion in P. aeruginosa persistence. The observations made in 
these recent studies substantiated an earlier report in which rough 
mutants of P. aeruginosa lacking OSA had an LD
50
 that was 1000X 
higher than that of a wildtype strain in a mouse infection model 
(Cryz et al., 1984).
propertIes of P. aeruginosa lps that Influence Its InteractIon 
wIth the defense systems of the host
The genomic stability of P. aeruginosa is such that environmental 
isolates have been found to maintain the potential for pathogenicity 
through the conservation of numerous virulence-associated genes 
required for host infection (Wolfgang et al., 2003). Undoubtedly, 
theses genetic traits contribute to the success of the bacterium as 
an opportunistic pathogen. In humans, opportunistic infection 
by P. aeruginosa is often seen in patients with varying degrees of 
compromised host defenses such as those suffering from damaged 
corneal lenses, cancer, AIDS, severe burn wounds, and CF (Lyczak 
et al., 2000). As with the more environmental physiological aspects 
described above, LPS of P. aeruginosa plays multiple key roles in the 
interaction between the pathogen and the infected host through 
direct engagement or evasion of innate and adaptive immune sys-
tem responses.
During the course of infection, it is a general understanding that 
the humoral adaptive immune response has a lag phase of between 
5 days to a week from initial infection detection; in that time period, 
the innate immune system plays an essential role in engaging and 
bIoloGIcal ImplIcatIons of lps dIversIty In 
P. aeruginosa
colonIzatIon and persIstence
Physiological adaptability and metabolic plasticity have long been 
hallmarks of P. aeruginosa survival, traits that were consistent with 
the annotated genome sequence for strain PAO1, which revealed a 
wealth of predicted genes involved in various synthesis, assembly, 
metabolic, regulatory, and pathogenesis paradigms (Stover et al., 
2000). This genomic abundance reflects the remarkable versatility 
of this bacterial species to colonize and persist in diverse niches 
ranging from different environmental settings to host animal tissues 
(Wolfgang et al., 2003). While several characteristics of P. aeruginosa 
facilitate initial substratum colonization and later-stage persistence, 
each is either directly or indirectly affected by variations in the 
phenotype of the LPS present on the cell surface.
In the aqueous environment, cells of P. aeruginosa swim with 
the aid of a polar flagellum (Feldman et al., 1998), but this mode 
of motility was impaired in mutants that lacked wildtype smooth 
LPS due to defects in either core OS biosynthesis, yielding truncated 
core OS (Lindhout et al., 2009), or ligation of OSA and CPA to the 
core OS, in the case of a waaL mutant (Abeyrathne et al., 2005). 
Swarming motility of P. aeruginosa cells, which is the process of 
translocation on semi-solid surfaces dependent on flagella, type IV 
pili, and rhamnolipid (a wetting agent produced by P. aeruginosa; 
Köhler et al., 2000), was similarly compromised in the aforemen-
tioned mutants with truncated core OS. The motility defects in the 
mutants were found to be a result of changes in cell-surface prop-
erties such as cell-to-cell and cell-to-substratum adhesion forces. 
Both types of adhesive forces became significantly increased in 
the mutants, as measured by AFM. This is in contrast to the initial 
thoughts that LPS defects might have somehow affected flagella-
driven motility. In fact, when the mutant cells were examined by 
standard light microscopy, and the swimming speed of individual 
cells was quantified, no difference could be discerned between the 
mutant and the wildtype parent strain. The increased adhesive 
properties retarded all outward motility from the population of 
P. aeruginosa cells (Lindhout et al., 2009).
Biofilm formation is the preferred mode of growth for P. aer-
uginosa cells clinging to rocks in fluvial streams or surviving in the 
lungs of CF patients in a chronic infection situation (Hall-Stoodley 
et al., 2004). Following planktonic growth of P. aeruginosa, attach-
ment to a substratum is a prerequisite for establishing long-term 
colonization at a particular site to eventually adapt to a biofilm 
mode of growth. Biofilms are intricate surface-associated bacterial 
communities that confer survival advantages to the cells residing 
within and for which flagellar-mediated motility is important for 
their maturation in P. aeruginosa (O’toole and Kolter, 1998; Klausen 
et al., 2003). Consistent with the motility defects described above, 
the same mutants of P. aeruginosa lacking complete core OS and 
the distal CPA and OSA moieties were found to form biofilms 
with significant differences in mechanical and structural proper-
ties when compared to those of wildtype bacteria. This evidence 
was collected from a variety of quantitative measurement studies 
to determine changes in ultrastructures, biophysical properties, 
cell–cell adhesion forces, and viscoelasticity of mutant and wildtype 
strains using a technique called microbead force spectroscopy 
(Lau et al., 2009a). Several bacterial strains including knockout 
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FIgure 6 | Images obtained from Atomic Force Microscopy analyses of P. aeruginosa cells collected in contact mode in air. (A) Strain PAO1; (B) migA mutant; (C) 
wapR mutant; (D) rmlC mutant. Height images (top panels) are shown with enclosed areas for roughness calculations. Deflection images (bottom panels) reveal more 
details in cell morphology. The straight lines in (A) are steps in the mica substratum. Reproduced from Lau et al. (2009b), with permission from Copyright Clearance Centre.
managing the infection through a variety of mechanisms. One such 
mode of action involves the recognition of pathogen-associated 
molecular patterns (PAMPs) by various pattern recognition recep-
tors in the host (Janeway and Medzhitov, 2002). Arguably, the most 
widely described reaction of the innate immune system to LPS is 
that of endotoxicity resulting from recognition of the distal lipid 
A moiety by the host Toll-like receptor 4 (TLR4) complex, which 
consists of the TLR4 receptor, the co-receptor component MD-2, 
and the GPI-linked LPS binding protein CD14 (Da Silva Correia 
et al., 2001; Hajjar et al., 2002; Palsson-Mcdermott and O’neill, 
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the TLR4 complex (Hajjar et al., 2002). In contrast, LPS with penta-
acylated lipid A is less potent. Compared to enterobacterial lipid 
A which has the hexa-acyl form with longer chain fatty acids (C14 
versus C10–C12), P. aeruginosa lipid A showed a significantly lower 
toxicity in an experimental animal model infection (Takada and 
2004; Miller et al., 2005). As discussed earlier, during adaptation 
of P. aeruginosa to the CF airway, the normally penta-acylated lipid 
A of the bacterium (Figure 5, lipid A form B) was modified to a 
hexa-acylated form (Figure 5, lipid A form D; Ernst et al., 2003), 
becoming a more robust proinflammatory stimulus  mediated by 
FIgure 7 | Images from confocal laser scanning microscopy analyses of 
P. aeruginosa cells that illustrate the changes in biofilm structure 
resulting from truncation in the LPS core in mutant strains as comparing 
to the wildtype bacteria. Average projections (top panels) and midpoint 
cross sections (bottom panels) of representative microcolonies of (A) 
wildtype strain PAO1, (B) migA mutant, (C) wapR mutant, and (D) rmlC 
mutant are shown. Reproduced from Lau et al. (2009b), with permission from 
Copyright Clearance Centre.
Lam et al. Pseudomonas aeruginosa LPS
www.frontiersin.org June 2011 | Volume 2 | Article 118 | 17
 mannan-binding lectin (MBL) pathways, each of which results in 
activation of C3 to yield C3b; in turn, this can lead to opsonization 
of pathogens and engulfment by phagocytes or surface deposition 
of complement components C5b, C6, C7, C8, and C9 to form the 
lytic membrane-attack complex (Dunkelberger and Song, 2010). In 
a murine model of P. aeruginosa-induced pneumonia, C3-deficient 
mice displayed higher mortality rates than C3-expressing mice. 
The C3-deficient mortality rates were similar to those observed for 
mice deficient in ACP-specific factor B, but not for mice deficient 
in CCP- and MBL-specific C4, indicating a critical role for the ACP 
in controlling initial P. aeruginosa pulmonary infection. Phagocytic 
cells from both the C3-expressing and C3-deficient mice displayed 
a reduced capacity in vitro to bind and take up P. aeruginosa in 
the presence of C3-deficient serum compared to C3-containing 
serum, suggesting that phagocytic clearance of the bacterium via 
C3-mediated opsonization constitutes a part of the protection 
afforded by the ACP against P. aeruginosa infection(Mueller-Ortiz 
et al., 2004).
Clinical isolates of P. aeruginosa from CF patients, deficient 
in long-chain O-Ag production, were found to be sensitive to 
pooled normal human serum (PNHS) when compared to subcul-
tured derivatives of the parental strains with restored O-Ag chain 
biosynthesis, which were found to be serum resistant (Schiller 
et al., 1984). The same derivative strains with restored O-Ag 
biosynthesis were subsequently shown to activate (i.e., consume) 
more complement from PNHS per bacterial organism than their 
O-Ag-deficient parental counterparts. Serum-sensitive strains 
were observed to accumulate more C3 than serum-resistant 
strains, with the C3 accumulation also occurring more rapidly 
in the former; both of these phenotypes were reduced upon 
prior treatment of the PNHS with ethylene glycol tetraacetic 
acid (EGTA, which blocks the CCP), suggesting that the CCP is 
important for maximal deposition of C3. Analysis of the form 
of C3 deposited on the surface of the various serum-sensitive 
and serum-resistant strains indicated equivalent amounts of 
C3b and iC3b (proteolytically inactivated C3b) in the former, 
while the latter contained mostly iC3b (Schiller et al., 1989). 
Taken together, these results indicate that complement-mediated 
responses to P. aeruginosa are an important part of the infection 
resolution mechanism, which is directly affected by the presence 
of O-Ag on the bacterial surface.
Sugar-binding proteins known as lectins, of which there are 
several classes, are also known to play a role in the innate immune 
response to P. aeruginosa infection. Surfactant proteins A (SP-
A) and D (SP-D) are part of the calcium-dependent, collagen-
ous C-type lectin family, containing carbohydrate-recognition 
domains. In the lung, they are secreted into the mucus lining the 
epithelium wherein they facilitate clearance of microbial pathogens 
via agglutination, neutralization, and opsonization (Holmskov et 
al., 2003). SP-A and SP-D have been shown to bind both rough 
and smooth strains of P. aeruginosa (Bufler et al., 2003), with SP-D 
interacting specifically with LPS (Kishore et al., 1996); inciden-
tally, both surfactant proteins have been shown to be important 
for clearance of P. aeruginosa (Levine et al., 1998; Mariencheck 
et al., 1999; Restrepo et al., 1999; Ni et al., 2005) but are present at 
reduced levels in the lungs of CF patients (Postle et al., 1999). In 
a separate investigation, the signal from biotin-labeled LPS from 
Kotani, 1992; Backhed et al., 2003). On the surface, direct stimula-
tion of the innate immune system by P. aeruginosa would appear 
to be a curious survival strategy for a pathogen that establishes 
chronic infections in CF patients; however, this strongly points to 
an as-yet-to-be-determined survival advantage for P. aeruginosa 
conferred by constant inflammation of the airway epithelium. 
Conversely, this sequence of proinflammatory responses has been 
recognized as a direct contributing factor to the gradual deteriora-
tion of lung capacity in CF patients with P. aeruginosa infection 
(Hoiby et al., 2010).
Modifications to the lipid A domain of LPS may also con-
fer other survival advantages. The host innate immune system 
produces a wide range of CAMPs, and some of them (such as 
cecropin and human defensin) directly interact with bacterial 
membranes (Hancock and Diamond, 2000). The addition of 
positively charged aminoarabinose to the phosphate groups of 
lipid A reduces the permeability of the OM or the affinity of lipid 
A for those CAMPs, and has clearly been shown to promote P. 
aeruginosa resistance to CAMPs; thus, such modifications may 
increase bacterial survival rates during host colonization (Ernst 
et al., 1999, 2007; Macfarlane et al., 2000; Moskowitz et al., 2004; 
Trent, 2004).
The principal genetic defect resulting in altered physiology of 
patients with CF is a loss of function of the CF transmembrane 
conductance regulator (CFTR), a chloride ion channel impor-
tant for maintaining the optimal viscosity of mucus membranes. 
Impaired CFTR function results in the production of mucus that is 
highly viscous, creating an ecological niche in the respiratory tract 
similar to a biofilm matrix, ideal for colonization by P. aeruginosa 
(Gibson et al., 2003). However, in addition to the increased viscos-
ity of the lung environment, a deficiency in binding of P. aeruginosa 
by CFTR also contributes to pathogenesis. Uptake of bacteria by 
airway epithelial cells has been implicated as a key mechanism for 
clearance of P. aeruginosa and CFTR was shown to play a role as 
a receptor and contribute to epithelial internalization (Bajmoczi 
et al., 2009). Murine cells lacking recombinant human CFTR, as 
well as those expressing the predominant ∆F508 CFTR mutant, 
displayed significant impairment in the binding and endocytosis 
of P. aeruginosa, compared to expression of the wildtype human 
protein (Pier et al., 1997), with the core OS portion of the LPS 
molecule of the bacterium implicated as the ligand responsible for 
uptake (Pier et al., 1996). As such, in individuals with wildtype 
CFTR, clearance of P. aeruginosa is mediated by uptake of the 
infecting bacteria via binding to CFTR and subsequent internali-
zation. However, studies of experimental eye infections demon-
strated that CFTR-mediated internalization of P. aeruginosa by 
corneal epithelial cells is essential to the development of keratitis 
(Zaidi et al., 1999), a potentially severe infection of the ocular lens 
often developed by individuals that frequently wear contact lenses 
(Robertson et al., 2007). In this scenario, the core OS-mediated 
interaction of CFTR with P. aeruginosa is detrimental to the human 
host rather than beneficial.
Activation of the complement cascade, which is comprised of 
more than 30 serum and cell-surface proteins, is another response 
of the innate immune system essential to combating infection. 
Three known mechanisms lead to activation of the comple-
ment system, namely, the classical (CCP), alternative (ACP), and 
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the core OS domain of P. aeruginosa LPS (Meadow and Wells, 
1978; Jarrell and Kropinski, 1981b; Temple et al., 1986; Yokota 
et al., 1994).
Analogous to the binding of P. aeruginosa by bacteriophage is the 
interaction of pyocins with the surface of the bacterium. Pyocins 
are chromosomally encoded by over 90% of P. aeruginosa strains 
and are inducible upon treatment with certain mutagenic agents. 
Depending on the type of pyocins, which might behave like lytic 
proteins or phage-like particles, they can disrupt the membranes 
of both related and unrelated bacteria, but which normally have 
no effect on the host strain (Michel-Briand and Baysse, 2002). 
Three principal pyocin types have been described, with the R-type 
(rod-shaped) pyocins closely resembling the contractile tails of 
bacteriophage. Specifically, R-type pyocins are related to ϕCTX bac-
teriophages (Hayashi et al., 1994), with core OS serving as a recep-
tor. Five subtypes of R-type pyocins (R1–R5) have been described, 
each with different killing spectra. Using a collection of well-defined 
LPS-deficient P. aeruginosa knockout mutants generated by our 
group, the RhaA, GlcII, and GlcI/GlcIII core sugars (Figure 5) were 
identified as receptors for R1, R2, and R5 R-type pyocins, respec-
tively. Therefore, spontaneous truncations of the core OS provide 
resistance to some of the R pyocins. The presence of OSA on the 
surface of P. aeruginosa was demonstrated to provide a “shield” 
against pyocin-mediated killing (Köhler et al., 2010).
treatment and preventIon of InfectIon
Upon infection with P. aeruginosa, leading treatment regimens 
often involve doses of antibiotics such as oral ciprofloxacin, or 
aerosolized drugs including TOBI® (inhaled tobramycin therapeu-
tic), or colymycin (inhaled colistin–lysin) that are currently being 
used to treat CF patients nowadays (Anderson, 2010). Tobramycin 
belongs to the family of aminoglycosides that inhibits bacterial 
protein biosynthesis via irreversible binding to the 30S bacterial 
ribosome (Edson and Terrell, 1999). Aminoglycosides such as gen-
tamicin have also been shown to disrupt the cell envelope of P. 
aeruginosa (Martin and Beveridge, 1986; Walker and Beveridge, 
1988), leading to lysis of the bacterium (Kadurugamuwa et al., 
1993a). Irrespective of its mechanism of bactericidal activity, the 
initial event in gentamicin-mediated treatment of infection involves 
ionic binding of the drug to the surface of P. aeruginosa. However, 
comparison of a wildtype strain with isogenic mutants lacking vari-
ous LPS glycoforms indicated a higher affinity of OMs containing 
OSA for gentamicin. Furthermore, OSA-expressing strains were 
more susceptible to killing via gentamicin treatment, with viabil-
ity reduced almost 50% in strains simultaneously expressing OSA 
and CPA as a result of higher antibiotic binding than in any other 
strain (Kadurugamuwa et al., 1993b). The importance of OSA in 
gentamicin binding has direct implications for the treatment of 
CF patients, as chronic P. aeruginosa isolates often lose the abil-
ity to synthesize OSA, while LPS capped with CPA is maintained 
(Hancock et al., 1983; Lam et al., 1989).
Given the ability of various phages to specifically and selectively 
target their respective host bacterium, combined with their overall 
lack of eukaryotic epitope recognition, the use of phage to control 
bacterial infection is once again gaining attention in the medical 
community after a prolonged period of research dormancy in the 
field (Hanlon, 2007) This is of particular interest in light of the 
P. aeruginosa was shown to overlap with that obtained with anti-
bodies against the S-type lectin galectin-3 via Western blotting 
of human corneal epithelial proteins, suggesting binding of the 
LPS by galectin-3. Additionally, pretreatment of scarified corneas 
in whole-eye culture with mAbs against either the outer core OS 
from P. aeruginosa or galectin-3 was found to inhibit binding of 
the bacterium to the cornea (Gupta et al., 1997). Coupled with 
the importance of SP-A and SP-D described above, the capacity 
of galectin-3 in binding of P. aeruginosa indicates a significant 
role for LPS-dependent lectin-mediated clearance of P. aeruginosa 
infection via the innate immune response.
It has been demonstrated that the type III secretion system 
(T3SS) of the bacterium mediates direct virulence-promoting 
primary interactions between P. aeruginosa and the host. This 
pathogenesis mechanism involves the highly regulated contact-
dependent insertion of a needle-like injector assembly into a host 
cell by the surface-associated bacterium, followed by the extru-
sion of four principal effector proteins (ExoS, T, U, Y) from the 
bacterium directly into the cytosol of the host cell. These type III 
effector proteins display a wide range of substrate specificities and 
in turn perturb a diverse range of host cell functions (Hauser, 2009). 
Intriguingly, upon comparison of isogenic LPS mutants to wildtype 
P. aeruginosa, the relative levels of expression of exoS and exoT 
(encoding effectors) exsA (encoding the positive T3SS regulator), 
and pcrV (encoding the injection-facilitation component) displayed 
marked increases in the absence of OSA. Even more pronounced 
increases in gene expression were observed in the simultaneous 
absence of OSA and CPA, suggesting a strong regulatory association 
between the presence/absence of capped core OS and T3SS effector 
expression (Augustin et al., 2007). Intracellularly, the production 
of ExoS and PcrV were found to be reflective of upregulated gene 
expression. P. aeruginosa mutants defective in OSA and CPA were 
also found to confer increased cytotoxicity in vitro and in vivo in 
lung epithelial cells and a murine model of infection, respectively 
(Augustin et al., 2007), indicating that the presence of O-Ag is an 
important factor contributing to the regulation and expression of 
T3SS effectors.
Notwithstanding either innate immune system interplay or 
T3SS activity, the host–pathogen interaction dynamic is also 
applicable with P. aeruginosa as the host and bacteriophage as the 
infectious agents. To date, multiple motifs on the LPS molecule 
of P. aeruginosa have been identified as receptors for various bac-
teriophages. As discussed earlier, bacteriophage A7 was found to 
bind and hydrolyze the d-Rha of CPA in a P. aeruginosa mutant 
devoid of OSA (Rivera et al., 1992). In addition, specificity for OSA 
has also been identified through examination of bacteriophage D3; 
lysogenization with the phage resulted in a loss of adsorption with 
the same phage during subsequent infection cycles (Holloway and 
Cooper, 1962), a phenotypic alteration later identified to be a result 
of acetyl-group addition at the d-Fuc residue as well as alteration 
of the linkage stereochemistry between OSA repeat units from 
α1 → 4 to β1 → 4, resulting in serotype conversion. Lysogenization 
by D3 also impeded the binding ability of the unrelated LPS-
specific phage E79 (Kuzio and Kropinski, 1983). The core OS of 
the bacterium is not only an important ligand for interaction with 
eukaryotic cells, but it is also a receptor for bacteriophages. Phages 
ϕCTX, ϕPLS27, E79, and H22 have all been shown to recognize 
Lam et al. Pseudomonas aeruginosa LPS
www.frontiersin.org June 2011 | Volume 2 | Article 118 | 19
continued development of widespread resistance to antibiotics, 
including isolates of P. aeruginosa, a bacterium already known to 
possess high intrinsic antibiotic resistance. As such, with a range 
of P. aeruginosa-specific bacteriophages identified (Ceyssens and 
Lavigne, 2010), phage therapy could serve as an alternative or com-
plementary method to the treatment and management of infections 
with this bacterium. One such example is the recently identified 
LPS-specific phage JG024 which was found to efficiently lyse a 
wide range of environmental and clinical isolates of P. aeruginosa 
(Garbe et al., 2010).
Rather than intervention through therapeutic measures after 
an infection has occurred, researchers have pursued prevention 
of P. aeruginosa colonization through the use of immunogenic 
vaccines to foster sustained adaptive immunity (Stanislavsky and 
Lam, 1997). Various vaccine formulations have been tested in a 
range of healthy and compromised individuals, using mixtures of 
LPS from different serotypes, different LPS components, immu-
nogenic toxins conjugated to LPS components, and inactivated 
whole-cell preparations, all traditionally administered via injec-
tion (Stanislavsky and Lam, 1997; Sedlak-Weinstein et al., 2005). 
While certain vaccine trials involving whole-molecule LPS prepa-
rations have yielded increased anti-LPS antibody titres, most LPS 
vaccines have been characterized by various toxic side effects, 
yielding inconsistent results with varying degrees of sustained 
protection (Sedlak-Weinstein et al., 2005). Furthermore, certain 
instances of non-Pseudomonas microbe replacement have also 
been identified following testing of LPS vaccines (Pennington 
et al., 1975; Jones et al., 1979). To circumvent issues of pyrogenic-
ity associated with purified LPS used for injection, lipid A-core 
OS from P. aeruginosa (and three other species) was reconstituted 
in liposomes and used to immunize rabbits, resulting in a well-
tolerated vaccine that induced the production of cross-reactive 
anti-core OS antibodies against a large panel of pathogenic 
Gram-negative bacteria expressing both rough and smooth LPS 
(Bennett-Guerrero et al., 2000); this same liposomal formula-
tion was later demonstrated to reduce the induction of TNF-α 
production in vitro when compared to the equivalent amounts 
of the purified LPS constituents (Erridge et al., 2002). As such, 
liposomal reconstitution may provide a means of reducing the 
endotoxic effects of LPS vaccine while still maintaining their pro-
tective efficacy.
In comparison to immunization with whole-molecule LPS, 
OSA vaccines are well tolerated. Correlation between the length 
of the OSA polymer and the production of protective antibodies 
was demonstrated in mice, with OSA containing over 18 repeat 
units inducing 50- to 100-fold increases (Macintyre et al., 1986). 
In CF patients not previously infected by P. aeruginosa, immuni-
zation with an octavalent OSA vaccine conjugated to exotoxin A 
was found to elicit high levels of anti-OSA antibodies in the serum 
(Lang et al., 1995), a trend sustained with yearly immunizations 
for a decade (Zuercher et al., 2006). These regular immunizations 
with the octavalent OSA-exotoxin A conjugate vaccine were found 
to delay the occurrence of colonization and reduce the frequency 
of chronic infection in young CF patients (Lang et al., 2004), 
demonstrating promise as a potential commercialized vaccine to 
prevent P. aeruginosa infection. Another method to induce protec-
tive immunity against P. aeruginosa has been through the genera-
tion of recombinant immunogens involving the OSA from certain 
 serotypes. Heterologous expression of P. aeruginosa O11 OSA in an 
attenuated strain of S. enterica sv. Typhimurium, followed by intra-
nasal immunization, resulted in the production of OSA-specific 
antibodies in the serum of immunized mice. Complete protection 
with the immunization was also provided against respiratory chal-
lenges until 6 months post-vaccination as well as against infection 
from a burn wound, while only partial protection was provided 
against corneal infection (Digiandomenico et al., 2007). This is a 
novel method for the stimulation of adaptive immunity against 
P. aeruginosa. However, despite the data from some of these stud-
ies demonstrating efficacy of the vaccine formulations in animal 
models, obvious hurdles must be overcome before the vaccines can 
be administered to CF patients. One of these would be the devel-
opment of an effective and accurate diagnostic method to deter-
mine whether or not a young CF patient has been colonized by P. 
aeruginosa. Infected patients produce high amounts of antibodies 
against LPS. Therefore, administering a vaccine to a patient who 
has previously been colonized by P. aeruginosa can have deleteri-
ous effects due to the formation of immune complexes between 
specific antibodies against P. aeruginosa surface antigens, such as 
LPS, and the vaccine antigens. The presence of these immune 
complexes could lead to serum sickness. Ultimately, the continued 
pursuit of an effective anti-P. aeruginosa vaccine involving LPS 
(whole or in part) is an important avenue of research that will 
undoubtedly benefit millions of people suffering from a range of 
medical conditions.
Considering all of the aforementioned biological implications 
of LPS diversity in P. aeruginosa, it is indisputable that the bacte-
rium follows a very complex infection dynamic, involving a mul-
titude of simultaneous interactions with the host, many of which 
it can exploit to further pathogenesis and its continued survival 
upon infection; yet a majority of these virulence mechanisms are 
affected, either directly or indirectly, by the LPS of the pathogen. 
As such, continued research into the biosynthesis and assembly of 
this important cell-surface virulence factor is essential to clearly 
understanding the colonization process and eventually controlling 
or inhibiting infection by P. aeruginosa.
conclusIon
In this review, we have provided a comprehensive account of 
the genetics for the biosynthesis of each of the three regions of 
P. aeruginosa LPS. We have also provided a critical review of the 
information in the literature pertaining to knowledge of how the 
variation in producing each region of the LPS can impart diversity 
to this species. External factors such as temperate bacteriophages 
that recognize LPS epitopes as receptors, followed by internaliza-
tion and propagating the viral life cycle, also influence diversity 
of LPS. All of these different factors account for the heterogeneity 
of P. aeruginosa, not only of the chain length of the O-Ag, but also 
of the chemical make up that accounts for the different serotypes. 
We close out the discussion by addressing the importance of LPS in 
host–pathogen interactions and the strategies that researchers use 
to target this cell-surface glycolipid to develop effective vaccines or 
novel antimicrobial interventions against P. aeruginosa infections. 
Suggestions for future research have been integrated throughout 
the various sections.
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